You are here

Bioiberica at EULAR, ACR and OARSI Conferences

2 Feb 2009
Healthcare

Bioiberica closed 2008 by participating in the three most important international conferences on diseases of the musculoskeletal system: those organized by EULAR, OARSI and ACR.

Bioiberica presented new clinical-efficacy and safety data on chondroitin, as well as a new line of scientific research on the product as a modulator of chronic inflammation.

Related News

10 May 2022
Healthcare

Bioiberica unveils DAOgest and Dermial® for the first time at Vitafoods 2022. 

11 Mar 2022
Healthcare

Formulated with Bioiberica’s Collavant n2, Highflex type II collagen tablets meet unmet consumer needs for innovative, low dose joint health solutions in China.